About iCellate

iCellate is a Swedish, medical technology company founded in 2011 and is based in Stockholm. iCellate develops products in the areas of cancer diagnosis and individual cancer treatment. The technology is based on research from the Karolinska Institute in collaboration with the Karolinska University Hospital and the Royal Institute of Technology in Stockholm.

The company is today part of the Uppsala Innovation Center (UIC) and has over the years received several awards from both scientific institutions and private companies.